Skip to main content

Fiscal Wizard · Single-issue tearsheet

TMO / Aug 13, 2026 Run #13817

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Composite verdict

B 65.0 / 100
Bullish setup · Trend Following 15 drivers · 2 gates blocking
  • Trendline Break
  • Vortex Signal
  • Keltner Channels
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 6th of 11 in Diagnostics & Research

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 21 signals0% Bear
Momentum Bullish 98Mean-reversion Neutral 51

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -73%
Asset value $144.44Earnings power value $145.03Price $603.01

Priced above its no-growth earnings power value ($145.03/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Weak

30.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Cash Conversion 88
PEGY 0
OCF to Net Income 67
PEG 0
Margin of Safety 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Trendline Break, Vortex Signal, Keltner Channels); bears gated by guards. · 44 signals shown.

Strongest
Weakest
Trendline Break 92
Vortex Signal 89
Keltner Channels 89

Risk Gates

2 blocking 8 caution

2 guards active, 19 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Debt-to-Assets Caution

High debt-to-assets blocks bullish signals — balance-sheet leverage risk.

Interest Coverage Caution

Weak interest coverage blocks bullish signals — debt-service risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for TMO.